Press release

Hologram Sciences unveils new initiatives to transform wellness through personalized health & nutrition

New York, 23rd February

·          Launch of consumer brand Phenology™ dedicated to personalized women’s health

·          Exclusive German start-up partnership for breakthrough biomarker monitoring platform

Hologram Sciences, the personalized nutrition pioneer, is targeting a revolution in health & wellness with the unveiling of its new consumer brand concepts addressing key health concerns through novel data-driven approaches. The company is building its product offering around an innovative portfolio of nutritional supplements and wellness products, symptom tracking, and advice delivered through a digital platform.

Introducing timely tailored natural menopausal management

Hologram Sciences’ new consumer brand, PhenologyTM, offers advanced at-home diagnostics, hormone tracking and custom insights for women before, during and after menopause. Fully personalized to their unique needs, users can follow a targeted wellness program with appropriate supplements and science-backed, naturally powerful health and beauty essentials. They can also access one-on-one coaching and expert advice to unlock timely relief throughout their menopause journey.

PhenologyTM is steered by a women-led team of experts, scientists and advisors seeking to advance science and subject matter expertise in an area largely overlooked by the medical profession. The brand will launch initially in North America.

Breakthrough non-invasive biomarker monitoring platform

Hologram Sciences is also unveiling a new, exclusive, partnership with femtech start-up Inne. The German-based company has developed the world’s first at-home non-invasive fertility monitoring system. The novel diagnostic and tracking platform uses saliva to determine hormone levels in real time. Already CE certified for use in the European Union, and with US FDA certification in progress, Inne’s portable “minilab” has wider potential applications along a range of health conditions, closely aligned with the Hologram Sciences roadmap.

Eirini Rapti, co-founder and CEO of Inne, said, “The partnership with Hologram Sciences is a superb foundation to bring our technology forward to change the lives of even more people. Through Hologram’s support we will be able to boost the development of our analytes and scale the at-home minilab for a range of concepts. Together we can help take away some of the mystique and apprehension many people feel when wanting to track personal health”.

CEO of Hologram Sciences, Ian Brady, said, “The importance of usable, convenient and non-invasive testing devices cannot be underestimated. Until recently many diagnostics could only be reliably performed on blood, and we are thrilled to be announcing our partnership with Inne as they offer a genuine alternative for a range of biomarkers. Going forward this will be key to the easy adoption of personalized nutrition solutions by consumers and we will be working tightly with Inne on integrating their platform as a crucial component in our concepts as we build a future of better personalized health”.

The collaboration between Hologram Sciences and Inne will cover both technological development for new analytes, as well as commercialization of the technology, and is in partnership with a strategic investment from DSM Venturing, the venturing arm of the global leader in health, nutrition and bioscience, DSM. Hologram Sciences last year launched its first consumer brand, d.velopTM, a novel platform offering personalized support for immunity health, including a supplement range containing DSM’s ampli-dTM ingredient – a fast-acting, more bioactive form of vitamin D.


About Hologram Sciences, Inc. Hologram Sciences is a newly formed, fast-moving, consumer-focused, start-up backed by Royal DSM. We rapidly develop and deliver new brands to market that to help people get healthier and feel better by reimagining the future of nutrition — bringing together proven science, pioneering technology, and habit-building to create truly personalized solutions that drive lasting consumer relationships. We are passionate about helping people overcome obstacles to feel better every day; we are grounded in transparency and proven clinical science; and, we are committed to creating products, and an organization, that are fully inclusive and equitable. More information can be found at

For more information

Jenny Mason

Barrett Dixon Bell
+44 161 925 4700